ILD patient registry at UPMC Simmons Center
Part of Lungs & breathing clinical trials.
This study is a registry that collects information from adults with interstitial lung disease (ILD) who are seeking care at the UPMC Simmons Center. It helps the center learn about ILD and improve future treatment planning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult age 18 or older
- You are seeking treatment at the UPMC Simmons Center for Interstitial Lung Disease
- You are able to participate in a center-based information registry
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial builds a European “registry and biobank” of children with suspected or confirmed interstitial lung disease (a type of lung problem), as well as conditions that can look similar. It helps researchers learn more about these rare childhood lung diseases and connect families to future studies.
This trial is a study database that collects information from adults who have other illnesses that can increase the risk of developing interstitial lung disease (lung scarring). It may help researchers better understand who is at risk and how outcomes change over time.
This registry is gathering information from people with different types of interstitial lung disease (ILD) across Taiwan. It aims to better understand the disease and improve future care.
This trial is for adults with interstitial lung disease (a group of lung conditions that cause scarring). It aims to understand the disease better and may help find new ways to treat it.
This study collects health information and may store blood or other samples to learn more about interstitial lung disease (ILD) and autoimmune-related conditions. Joining could help researchers understand different causes of ILD and improve future care.
This study builds a community registry to learn about people affected by pulmonary fibrosis and related lung conditions, including patients, caregivers, and close family. By joining, you help researchers better understand needs and experiences in the real world.
Hear when a new Lung Diseases, Interstitial trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.